DNTH vs GRMN · rev $6.2M vs P/E 28, rev $6.30B
Dianthus Therapeutics Inc. (DNTH) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported GRMN revenue for 2024-12-28 was $6.30B. Net income was $1.41B. Revenue was up 20.4% from 2023-12-30 to 2024-12-28. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
DNTH currently screens at market cap $4.40B. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the DNTH and GRMN stock pages for the full models.
Not investment advice.